| Issue |
J Extra Corpor Technol
Volume 32, Number 2, June 2000
|
|
|---|---|---|
| Page(s) | 107 - 110 | |
| DOI | https://doi.org/10.1051/ject/2000322107 | |
| Published online | 14 August 2023 | |
Case Report
The Use of r-Hirudin During Cardiopulmonary Bypass in a Patient with Heparin Induced Thrombocytopenia
Vanderbilt University School of Medicine, Department of Cardiac and Thoracic Surgery, Nashville, Tennessee
* Address correspondence to: David P. Webb, MS, CCP 2986 The Vanderbilt Clinic Nashville, TN, 37232
Heparin-induced thrombocytopenia and its related complications can be life-threatening in patients undergoing cardiopulmonary bypass (CPB) with heparin exposure. While the literature illustrates many different techniques which might be employed in this situation, most are used infrequently. This case report provides an overview of the successful use of r-Hirudin, and associated monitoring techniques, in a high-risk patient undergoing cardiac surgery utilizing CPB.
Key words: heparin-induced thrombocytopenia / HIT / r-Hirudin / cardiopulmonary bypass / hirudin
© 2000 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.